Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects

HIV increases the risk of liver disease as do two common coinfections, hepatitis B and C viruses (HBV and HCV). However, whether combination antiretroviral therapy (cART) reverses or exacerbates hepatic fibrosis remains unclear. This was an observational retrospective study. cART-naïve HIV-infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yijia, Xie, Jing, Han, Yang, Wang, Huanling, Lv, Wei, Guo, Fuping, Qiu, Zhifeng, Li, Yanling, Du, Shanshan, Song, Xiaojing, Zhu, Ting, Thio, Chloe L., Li, Taisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748910/
https://www.ncbi.nlm.nih.gov/pubmed/26844493
http://dx.doi.org/10.1097/MD.0000000000002660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748910/
https://www.ncbi.nlm.nih.gov/pubmed/26844493
http://dx.doi.org/10.1097/MD.0000000000002660

Ejemplares similares